Trials / Unknown
UnknownNCT03212001
TeleHomecaRe InterVention Evaluation Study
TeleHomecaRe InterVention Evaluation (THRIVE) Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,400 (estimated)
- Sponsor
- University of Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to evaluate the overall impact of Telehomecare on COPD and HF patients and system level outcomes using a comparison group of patients that did not participate in the program (for up to 18 months). This evaluation study will explore costs, participants' experiences, perceptions, and patterns of use related to Telehomecare. The study will include eight Local Health Integration Networks (LHINs) across Ontario, Canada.
Detailed description
The key question to answer is how different models of Telehomecare enabled self-management impacts patient outcomes, experiences and system costs across Ontario. The evaluation study will also attempt to answer questions on who is benefitting the most from the program and the quantifiable benefits a patient would experience from participating. The intervention evaluation study will use a mixed-methods design comprising of four components (sub-studies), using both qualitative and quantitative research methods: (1) Comparative Effectiveness Study that evaluates patient-level clinical outcomes (e.g. hospitalization, ED visits) using administrative data in comparison with usual care; (2) Economic Evaluation Study that will evaluate costs associated with the program and patient level outcomes as well as cost-effectiveness of the program in comparison with 'usual care'; (3) Evaluation study of Telehomecare use that will evaluate the patterns of program use and perceived quality of life, disease management, satisfaction and caregiver strain; and (4) Adoption study that will use ethnographic fieldwork, semi-structured interviews (during and after program participation) and review of documentary sources to gain understanding of program adoption.
Conditions
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2019-10-01
- Completion
- 2019-10-01
- First posted
- 2017-07-11
- Last updated
- 2019-04-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03212001. Inclusion in this directory is not an endorsement.